FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

8940801000001103: Re-introduced (qualifier value)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
40298601000001113 Re-introduced (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
40298701000001115 Re-introduced en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Re-introduced Is a Non-availability indicator true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Chlorpropamide 100mg tablets (The Boots Company) 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Testosterone 200mg implant (Organon Pharma (UK) Ltd) 1 device VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Testosterone 200mg implant (Unichem Plc) 1 device VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sodium fusidate 500mg powder and solvent for solution for injection vials (Unichem Plc) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Testosterone 200mg implant (Special Order) 1 device VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Fucidin 500mg powder and solvent for solution for injection vials (LEO Pharma) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Procyclidine 10mg/2ml solution for injection ampoules (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Minipress 2mg tablets (Imported (Australia)) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Prazosin 2mg tablets 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Procyclidine 10mg/2ml solution for injection ampoules (A A H Pharmaceuticals Ltd) 5 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Minipress 2mg tablets (Imported (Australia)) 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Berocca effervescent tablets mango (Bayer Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Berocca effervescent tablets mango (Bayer Plc) 15 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Berocca effervescent tablets mango (Bayer Plc) 30 tablet 2 x 15 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nurofen Express 256mg tablets (Reckitt Benckiser Healthcare (UK) Ltd) 12 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely nadolol 40 milligram/1 each conventional release oral tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Testosterone propionate 50mg/mL injection solution 2mL ampule VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Guaifenesin 100mg/5ml / Cetylpyridinium chloride 2.5mg/5ml oral solution sugar free VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Nadolol 40mg tablets 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Corgard 40mg tablets (Sanofi-Synthelabo Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Testosterone propionate 100mg/2ml solution for injection ampoules (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lemsip Cough for Mucus Cough Sugar & Colour Free 100mg/2.5mg/5ml oral solution (Reckitt Benckiser Healthcare (UK) Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Guaifenesin 100mg/5ml / Cetylpyridinium chloride 2.5mg/5ml oral solution sugar free 100 ml VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Nadolol 40mg tablets (Part VIIID Drug Tariff Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Adult Meltus Chesty Coughs Sugar & Colour Free oral solution (SSL International Plc) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Testosterone propionate 100mg/2ml solution for injection ampoules 10 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Virormone 100mg/2ml solution for injection ampoules (Nordic Pharma) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nadolol 40mg tablets 1 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Testosterone propionate 100mg/2ml solution for injection ampoules 1 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Adult Meltus Chesty Coughs Sugar & Colour Free oral solution (SSL International Plc) 100 ml VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Lemsip Cough for Mucus Cough Sugar & Colour Free 100mg/2.5mg/5ml oral solution (Reckitt Benckiser Healthcare (UK) Ltd) 100 ml VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Virormone 100mg/2ml solution for injection ampoules (Nordic Pharma) 10 ampoule 10 x 2ml ampoules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nadolol 40mg tablets (Part VIIID Drug Tariff Special Order) 1 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Testosterone propionate 100mg/2ml solution for injection ampoules (Special Order) 1 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Corgard 40mg tablets (Sanofi-Synthelabo Ltd) 28 tablet 2 x 14 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Zinc and Salicylic acid paste 100 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Zinc and Salicylic acid paste (Drug Tariff Special Order) 100 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Gaviscon Advance Mint chewable tablets (Reckitt Benckiser Healthcare (UK) Ltd) 60 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Acetylcysteine 10% preservative-free eye drops VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Hypromellose 0.25% eye drops preservative free VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Prednisolone sodium phosphate 0.03% eye drops preservative free VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Prednisolone sodium phosphate 0.1% eye drops preservative free VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Prednisolone sodium phosphate 0.3% eye drops preservative free VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Prednisolone sodium phosphate 0.1% eye drops preservative free (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Prednisolone sodium phosphate 0.03% eye drops preservative free 1 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Hypromellose 0.25% eye drops preservative free (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Prednisolone sodium phosphate 0.1% eye drops preservative free 10 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Prednisolone sodium phosphate 0.3% eye drops preservative free 10 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Prednisolone sodium phosphate 0.3% eye drops preservative free 1 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Prednisolone sodium phosphate 0.03% eye drops preservative free 10 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Prednisolone sodium phosphate 0.3% eye drops preservative free (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Prednisolone sodium phosphate 0.1% eye drops preservative free 1 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Acetylcysteine 10% eye drops preservative free 1 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Hypromellose 0.25% eye drops preservative free 10 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Hypromellose 0.25% eye drops preservative free 1 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Prednisolone sodium phosphate 0.03% eye drops preservative free (Part VIIID Drug Tariff Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Acetylcysteine 10% eye drops preservative free (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Acetylcysteine 10% eye drops preservative free 10 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Prednisolone sodium phosphate 0.03% eye drops preservative free (Part VIIID Drug Tariff Special Order) 1 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Acetylcysteine 10% eye drops preservative free (Special Order) 10 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Prednisolone sodium phosphate 0.3% eye drops preservative free (Special Order) 1 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Hypromellose 0.25% eye drops preservative free (Special Order) 1 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Acetylcysteine 10% eye drops preservative free (Special Order) 1 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Hypromellose 0.25% eye drops preservative free (Special Order) 10 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Prednisolone sodium phosphate 0.1% eye drops preservative free (Special Order) 1 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Prednisolone sodium phosphate 0.1% eye drops preservative free (Drug Tariff Special Order) 10 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Prednisolone sodium phosphate 0.3% eye drops preservative free (Special Order) 10 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Prednisolone sodium phosphate 0.03% eye drops preservative free (Part VIIID Drug Tariff Special Order) 10 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Promazine 50mg tablets (J M McGill Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sodium alginate 500mg / Potassium bicarbonate 100mg chewable tablets sugar free (J M McGill Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Promazine 50mg tablets (Pharma-z Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Promazine 50mg tablets (J M McGill Ltd) 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sodium alginate 500mg / Potassium bicarbonate 100mg chewable tablets sugar free (J M McGill Ltd) 60 tablet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Promazine 50mg tablets (Pharma-z Ltd) 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Fosfomycin 4g powder for solution for infusion vials VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Fomicyt 4g powder for solution for infusion vials (Kent Pharma (UK) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Fosfoscina Intravenosa 4g powder for solution for infusion vials (Imported (Spain)) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Fosfomycin 4g powder for solution for infusion vials 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Fosfomycin 4g powder for solution for infusion vials 10 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Fosfoscina Intravenosa 4g powder for solution for infusion vials (Imported (Spain)) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Fomicyt 4g powder for solution for infusion vials (Kent Pharma (UK) Ltd) 10 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Promazine 50mg tablets (Colorama Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sodium alginate 500mg / Potassium bicarbonate 100mg chewable tablets sugar free (Colorama Pharmaceuticals Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Promazine 50mg tablets (Colorama Pharmaceuticals Ltd) 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sodium alginate 500mg / Potassium bicarbonate 100mg chewable tablets sugar free (Colorama Pharmaceuticals Ltd) 60 tablet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely benzoic acid 60 milligram/1 gram and salicylic acid 30 milligram/1 gram conventional release cutaneous cream VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Benzoic acid 6% / Salicylic acid 3% cream 20 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Toepedo cream (Dendron Brands Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Benzoic acid 6% / Salicylic acid 3% cream 1 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Benzoic acid 6% / Salicylic acid 3% cream (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Benzoic acid 6% / Salicylic acid 3% cream (Special Order) 1 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Toepedo cream (Dendron Brands Ltd) 20 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely clofazimine 100 milligram/1 each conventional release oral capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Tetracosactrin 250micrograms/1mL injection VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Nicotinic acid 500mg m/r tablet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Tetracosactide 1mg/1ml suspension for injection ampoules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Clofazimine 100mg capsules (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Tetracosactide 1mg/1ml suspension for injection ampoules 10 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nicotinic acid 500mg modified-release tablets 1 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nicotinic acid 500mg modified-release tablets (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Niaspan 500mg modified-release tablets (Merck Pharmaceuticals) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier

Start Previous Page 61 of 86 Next End

This concept is not in any reference sets

Back to Start